W. Michael Scheid

590 total citations
15 papers, 449 citations indexed

About

W. Michael Scheid is a scholar working on Epidemiology, Microbiology and Pharmacology. According to data from OpenAlex, W. Michael Scheid has authored 15 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Microbiology and 6 papers in Pharmacology. Recurrent topics in W. Michael Scheid's work include Bacterial Infections and Vaccines (8 papers), Pneumonia and Respiratory Infections (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). W. Michael Scheid is often cited by papers focused on Bacterial Infections and Vaccines (8 papers), Pneumonia and Respiratory Infections (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). W. Michael Scheid collaborates with scholars based in United States, Switzerland and Brazil. W. Michael Scheid's co-authors include John S. Bradley, O. Zák, Joe P. Bryan, Merle A. Sande, M G Täuber, Michiel A. J. van de Sande, Vincent Quagliarello, B. Hengstler, Allan R. Tunkel and R. L. Cihlar and has published in prestigious journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases and Clinical Therapeutics.

In The Last Decade

W. Michael Scheid

15 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W. Michael Scheid United States	12	228	157	142	138	102	15	449
C. Watanakunakorn United States	11	159 0.7×	63 0.4×	57 0.4×	227 1.6×	112 1.1×	17	515
G Tunevall Sweden	11	178 0.8×	68 0.4×	163 1.1×	95 0.7×	115 1.1×	37	506
C T Eliopoulos United States	8	171 0.8×	30 0.2×	178 1.3×	272 2.0×	189 1.9×	8	507
Cynthia A. Needham United States	11	198 0.9×	62 0.4×	51 0.4×	158 1.1×	46 0.5×	20	436
S Ozeki Japan	10	127 0.6×	176 1.1×	128 0.9×	59 0.4×	218 2.1×	16	443
Martin J. Gill United Kingdom	8	323 1.4×	80 0.5×	245 1.7×	126 0.9×	314 3.1×	16	656
Benedict L. Wasilauskas United States	14	189 0.8×	104 0.7×	24 0.2×	96 0.7×	45 0.4×	38	417
R R Packer United States	11	187 0.8×	51 0.3×	208 1.5×	119 0.9×	189 1.9×	22	418
Linda A. Kirven United States	9	198 0.9×	177 1.1×	123 0.9×	74 0.5×	185 1.8×	9	492
H. Drugeon France	10	136 0.6×	39 0.2×	208 1.5×	94 0.7×	147 1.4×	37	481

Countries citing papers authored by W. Michael Scheid

Since Specialization

Citations

This map shows the geographic impact of W. Michael Scheid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Michael Scheid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Michael Scheid more than expected).

Fields of papers citing papers by W. Michael Scheid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Michael Scheid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Michael Scheid. The network helps show where W. Michael Scheid may publish in the future.

Co-authorship network of co-authors of W. Michael Scheid

This figure shows the co-authorship network connecting the top 25 collaborators of W. Michael Scheid. A scholar is included among the top collaborators of W. Michael Scheid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Michael Scheid. W. Michael Scheid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Henry, Dan, et al.. (1999). Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Clinical Therapeutics. 21(2). 340–352. 15 indexed citations

Bradley, John S. & W. Michael Scheid. (1997). The Challenge of Penicillin-Resistant Streptococcus pneumoniae Meningitis: Current Antibiotic Therapy in the 1990s. Clinical Infectious Diseases. 24(Supplement 2). S213–S221. 84 indexed citations

Quagliarello, Vincent & W. Michael Scheid. (1993). New Perspectives on Bacterial Meningitis. Clinical Infectious Diseases. 17(4). 603–610. 28 indexed citations

McCracken, George H., Merle A. Sande, Arnold Lentnek, Richard J. Whitley, & W. Michael Scheid. (1992). Evaluation of New Anti-Infective Drugs for the Treatment of Acute Bacterial Meningitis. Clinical Infectious Diseases. 15(Supplement_1). S182–S188. 8 indexed citations

Whitley, Richard J., Arnold Lentnek, George H. McCracken, Merle A. Sande, & W. Michael Scheid. (1992). Evaluation of New Anti-Infective Drugs for the Treatment of Viral Encephalitis. Clinical Infectious Diseases. 15(Supplement_1). S195–S199. 1 indexed citations

Sande, Merle A., Richard J. Whitley, George H. McCracken, Arnold Lentnek, & W. Michael Scheid. (1992). Evaluation of New Anti-Infective Drugs for the Treatment of Toxoplasma Encephalitis. Clinical Infectious Diseases. 15(Supplement_1). S200–S205. 2 indexed citations

Wispelwey, Brian, Allan R. Tunkel, & W. Michael Scheid. (1990). Bacterial Meningitis in Adults. Infectious Disease Clinics of North America. 4(4). 645–659. 14 indexed citations

Wispelwey, Brian, et al.. (1990). Pathogenesis and Pathophysiology of Meningitis. Infectious Disease Clinics of North America. 4(4). 555–581. 17 indexed citations

Tunkel, Allan R. & W. Michael Scheid. (1989). Applications of Therapy in Animal Models to Bacterial Infection in Human Disease. Infectious Disease Clinics of North America. 3(3). 441–460. 19 indexed citations

10.

Bryan, Joe P., et al.. (1986). Problems in Salmonellosis: Rationale for Clinical Trials with Newer -Lactam Agents and Quinolones. Clinical Infectious Diseases. 8(2). 189–207. 66 indexed citations

11.

Calderone, Richard, et al.. (1985). Yeast Adhesion in the Pathogenesis of Endocarditis Due to Candida albicans: Studies with Adherence-Negative Mutants. The Journal of Infectious Diseases. 152(4). 710–715. 62 indexed citations

12.

Täuber, M G, O. Zák, W. Michael Scheid, B. Hengstler, & Michiel A. J. van de Sande. (1984). The Postantibiotic Effect in the Treatment of Experimental Meningitis Caused by Streptococcus pneumoniae in Rabbits. The Journal of Infectious Diseases. 149(4). 575–583. 71 indexed citations

13.

Freedman, John, et al.. (1983). Moxalactam for the Treatment of Bacterial Meningitis in Children. The Journal of Infectious Diseases. 148(5). 886–891. 15 indexed citations

14.

Haley, E. Clarke, et al.. (1983). Treatment of Experimental Brain Abscess with Penicillin and Chloramphenicol. The Journal of Infectious Diseases. 148(4). 737–744. 14 indexed citations

15.

Zák, O., W. Michael Scheid, & Merle A. Sande. (1983). Rifampin in Experimental Endocarditis Due to Staphylococcus aureus in Rabbits. Clinical Infectious Diseases. 5(Supplement_3). S481–S490. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact